Artificial intelligence (AI) at NICE

We understand the importance of responsible and effective use of artificial intelligence (AI).

We're identifying the potential benefits that AI can bring to the health and care system, and how it can be used in the development of our guidance and advice.

Our approach

Artificial intelligence (AI) presents a significant opportunity to better deliver on our core mission and transform how we conduct our business. It can help improve health outcomes and system productivity, and drive innovation within the life sciences and health technology sectors. 

To date, NICE has been a world-leading HTA body in considering how AI can be applied to healthcare. We've led the way with the publication of both our AI Statement of Intent and position statement on the use of AI in evidence generation. We're also adopting AI across our processes, and have already published 17 evaluations of AI-based medical devices since 2023. 

Our plan for 2026/27 builds on ongoing work, as well as commitments in the 10 Year Health Plan and the AI Opportunities Action Plan. More broadly, our ongoing transformation will consider how AI and modern data and digital tools can best position us for the future.

You can find out more in our delivery plan: Unlocking growth by enabling safe AI innovation (Word).

Engage with us

If you would like more information about the use of AI at NICE, contact AI@nice.org.uk.

For pharmaceutical and healthtech companies seeking NHS market access, you can get reliable scientific advice and NHS insights direct from our NICE Advice service

Further information and resources

Subscribe to NICE news for life sciences

Our NICE news for life sciences newsletter keeps you up to date with important developments within the life sciences sector.